A drug originally used to boost the immune system is showing promise as a potential new treatment for lupus, joint Monash University and Peking University research published today shows. Lupus is an autoimmune disease, where the immune system attacks the body’s own organs and tissues.
An international team of scientists from Australia and China have, for the first time, shown in a study published in Nature Medicine, that a natural immune system protein called IL-2 can help restore balance to the overactive immune system of lupus patients. The drug could soon be rolled out for clinical trials in lupus treatment.
Monash Biomedicine Discovery Institute researcher, Dr Di Yu and Professor Zhanguo Li from Peking University People’s Hospital in China co-led the study.
Dr Yu said he hoped the drug could be approved as a lupus treatment within a handful of years.
“This drug, which can help the immune system fight against cancer, was approved in the 1990s but is not commonly used now. We’re now using this drug for a different purpose, based on our new knowledge of the immune system,” Dr Yu said.
“The amount we tested for treating lupus is much less than the dose used in treating cancers. We observed the treatment was safe and showed promising results, so there’s reason to believe formal trials could begin almost immediately,” he said.
Dr Yu said lupus could be a serious disease, and that it hadn’t been able to be treated in a very satisfactory way in the past.
IL-2 is a protein that regulates the activity of white blood cells, which are an important part of the immune system that protect the body against infections. In cancer therapy, patients are given large doses of IL-2 to stimulate their immune system but, paradoxically, the low dose IL-2 given to lupus sufferers in this study actually supressed the overactive part of their immune system that attacks their body. The research also showed the “self-checking” part of the immune system that prevents an overactive immune response, called regulatory T cells, increased after IL-2 treatment.
Professor Eric Morand, fellow Monash University researcher on the study and founder of the Asia Pacific Lupus Collaboration, said that in this study, IL-2 was given to people whose lupus wasn’t responding well to standard treatments.
“The real promise of this treatment is that it calms the hyperactive immune system through multiple mechanisms, which is very important as this new therapy may be effective for many patients,” Professor Morand said.
”As the drug has been on the market for some time for other diseases, it can be rapidly put into formal trials for lupus treatment right away.”
Learn more: Promising new treatment for lupus on the horizon
The Latest on: Lupus
[google_news title=”” keyword=”lupus” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lupus
- Belimumab is Safe and Effective in Older Adults with Lupuson March 27, 2023 at 4:42 pm
New study further confirms efficacy of Benlysta. The drug therapy is safe and effective in people with lupus ages 65+.
- How to Navigate Pregnancy With Lupuson March 27, 2023 at 12:16 pm
Perhaps you just found out you’re expecting, and you want to know what the next nine months will look like and how your lupus might affect your pregnancy. Lupus is a chronic autoimmune disease that ...
- Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Updateon March 27, 2023 at 10:33 am
Summary. clinical trial report, “Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update" provides an ...
- RINVOQ Advances to Phase 3 Clinical Trials for Lupus Treatmenton March 27, 2023 at 5:52 am
The drug therapy, RINVOQ, is advancing to Phase 3 clinical trials for further exploration as a potential lupus treatment.
- Tawam's Rheumatologists Successfully Treat A Patient With Lupus With A Novel Drugon March 27, 2023 at 5:09 am
The medicine has been approved by the U.S. Food and Drug Administration and the Ministry of Health and Prevention of the UAE based on studies from various countries around the world. The Rheumatology ...
- Systemic Lupus Erythematosus (SLE) Drugs Market | Insights and Opportunities for 2023-2030on March 27, 2023 at 4:59 am
Mar 27, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Latest “Systemic Lupus Erythematosus ...
- Prevalence & Clinical Associations of Enthesitis in SLE Examinedon March 27, 2023 at 2:00 am
The prevalence and clinical significance of enthesitis in SLE make an argument for the consideration of enthesitis as a musculoskeletal manifestation of SLE.
- ImmuPharma Shares Rise on Lupus Candidate FDA Trial Submissionon March 27, 2023 at 12:53 am
By Kyle Morris Shares in ImmuPharma PLC rose 9.4% on Monday after the company said it has submitted a Phase 2/3 clinical trial protocol to the U.S. Food ...
- UH surprises 10-year-old ball boy with lupus and kidney disorder with trip to Sweet Sixteenon March 24, 2023 at 6:52 pm
Prior to Friday's Sweet Sixteen matchup, ABC13 found a story bigger than basketball - and one that might just put a smile on your face. And delivering smiles is exactly what young Jace Abarca has done ...
- Time when Selena Gomez spoke about her weight gain and made us aware of her condition ‘Lupus’on March 22, 2023 at 4:38 am
Selena Gomez is in news currently due to a photograph she shared on Instagram in which she can be seen wearing a wedding gown. In 2015, Selena had rev ...
via Bing News